Filing status
- Accounts due
- 31 December 2027
- Last accounts
- 31 March 2026
- Conf. stmt due
- 15 May 2027
- Last conf. stmt
- 1 May 2026
Bensen Pharma Limited
- Incorporated
- 3 May 2023 (3 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Controlled by
- Andrew Richard Boyce
- Accounts type
- Total exemption full
- Region
- East of England
- Address
- Ruffles Barn BrooksideDalhamNewmarketCB8 8TG
Charges
- Total
- 2
- Outstanding
- 2
- Part satisfied
- 0
- Satisfied
- 0
Officers
Not loaded yet. See them on Companies House
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Andrew Richard Boyce
Individual · Notified 3 May 2023
Has significant influence or control
British
Born February 1962 (64)
Holdings 1
Companies where Bensen Pharma Limited is registered as a person with significant control
Owns 75–100% of shares
Active
Financials
Figures from 2025 accounts. Newer accounts, made up to 31 March 2026, are filed but not read yet. See them on Companies House
- Net Assets
- (£179,475)
- Cash
- £276
- Current Ratio
- 0.1x
Trend
Net Assets
Balance sheet detail
| 2025 | 2024 | |
|---|---|---|
| Current Assets | £28,290 | £8,154 |
| Cash | £276 | £2,590 |
| Creditors (< 1 year) | £288,122 | £196,042 |
| Net Current Assets | (£259,832) | (£187,888) |
| Net Assets | (£179,475) | (£107,531) |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 23 October 2026 | Statement of capital following an allotment of shares | |||
| 20 August 2026 | Total exemption full accounts | 31 March 2026 |
Some other companies at this address
Other companies in this industry
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →